在加拿大，坚持完成重组带状疱疹疫苗治疗的态度、障碍和促进因素：对医疗服务提供者和患者的定性访谈

IF 4.8 4区医学

Human Vaccines & Immunotherapeutics Pub Date : 2024-03-19 DOI:10.1080/21645515.2024.2317595

Sydney George, Jessica Regan, Amnah Awan, Meaghan O’Connor, April Foster, Kimberly Raymond, Iris Gorfinkel, Shelly A. McNeil

引用次数: 0

摘要

这项横断面定性研究旨在了解在加拿大坚持接种和完成重组带状疱疹疫苗 (RZV) 两剂系列接种的相关障碍和促进因素......

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and patients

This qualitative, cross-sectional study aimed to understand the barriers and facilitators related to the adherence and completion of the recombinant zoster vaccine (RZV) two-dose series in Canada, ...

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY

自引率

8.30%

发文量

审稿时长

1 months

期刊介绍： (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.